VALIANTLAB Share Price Target 2035

CAGR-based price projection for Valiant Laboratories Limited (VALIANTLAB) targeting 2035, derived from official NSE exchange closing prices.

Bear Case (31.9% CAGR)
Rs 1,265
2035 Target
Base Case (79.7% CAGR)
Rs 20,463
2035 Target
Bull Case (289.6% CAGR)
Rs 21,715,436
2035 Target

Current Market Snapshot

CMP: Rs 104.89
52W High: Rs 107.87
52W Low: Rs 58.38
1Y CAGR: 222.8%
3Y CAGR: 79.7%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 138 Rs 188 Rs 409
2028 Rs 182 Rs 339 Rs 1,592
2029 Rs 241 Rs 608 Rs 6,205
2030 Rs 317 Rs 1,093 Rs 24,178
2031 Rs 418 Rs 1,964 Rs 94,208
2032 Rs 552 Rs 3,528 Rs 367,077
2033 Rs 727 Rs 6,339 Rs 1,430,301
2034 Rs 959 Rs 11,389 Rs 5,573,116
2035 Rs 1,265 Rs 20,463 Rs 21,715,436

Other VALIANTLAB Price Targets

2025 2026 2027 2028 2030 2040 2050

Frequently Asked Questions

What is the VALIANTLAB share price target for 2035?

Based on historical growth analysis, the VALIANTLAB share price target for 2035 ranges from Rs 1,265 (conservative) to Rs 20,463 (base case) to Rs 21,715,436 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of VALIANTLAB?

The current market price of VALIANTLAB (Valiant Laboratories Limited) is Rs 104.89. The 52-week high is Rs 107.87 and 52-week low is Rs 58.38.

Is VALIANTLAB a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for VALIANTLAB price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 31.9% CAGR), Base (79.7% CAGR), and Bull (optimistic at 289.6% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.